Back
PagSeguro Digital Ltd. Vs. Enliven Therapeutics, Inc. Industry Stock Comparison
Sell
50
PAGS
PagSeguro Digital Ltd.
PAGS
PagSeguro Digital Ltd.
PagSeguro Digital Ltd.
Last Price:
$10.77
Seasonality Move:
10.12%
Sell
40
ELVN
Enliven Therapeutics, Inc.
ELVN
Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc.
Last Price:
$42.94
Seasonality Move:
9.15%
Sell
50
PagSeguro Digital Ltd. (PAGS)
is a Sell
Is PagSeguro Digital Ltd. a Buy, Sell or Hold?
-
The current PagSeguro Digital Ltd. [PAGS] share price is $10.54. The Score for PAGS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
PAGS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Enliven Therapeutics, Inc. (ELVN)
is a Sell
Is Enliven Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Enliven Therapeutics, Inc. [ELVN] share price is $43.16. The Score for ELVN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
ELVN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PAGS Stock Price Chart
What is PagSeguro Digital Ltd.'s stock price today?
-
The PagSeguro Digital Ltd. share price today is $10.54Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PAGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ELVN Stock Price Chart
What is Enliven Therapeutics, Inc.'s stock price today?
-
The Enliven Therapeutics, Inc. share price today is $43.16Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ELVN is experiencing buying pressure, which is a positive indicator for future bullish movement.
PAGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 55.93 | Buy |
| Chaikin Money Flow: | 3941266 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.59 - 10.33) | Buy |
| Bollinger Bands (100): | (9.6 - 10.86) | Buy |
ELVN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.28 | Buy |
| Relative Strength Index (14 RSI): | 74.46 | Buy |
| Chaikin Money Flow: | 2801753 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.87 - 37.43) | Buy |
| Bollinger Bands (100): | (18.99 - 31.53) | Buy |
PAGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.16 | Buy |
| 20-day SMA: | 9.92 | Buy |
| 50-day SMA: | 10.5 | Buy |
| 200-day SMA: | 9.67 | Buy |
| 8-day EMA: | 10.27 | Buy |
| 20-day EMA: | 10.13 | Buy |
| 50-day EMA: | 10.21 | Buy |
| 200-day EMA: | 9.82 | Buy |
ELVN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.08 | Buy |
| 20-day SMA: | 33.46 | Buy |
| 50-day SMA: | 30.05 | Buy |
| 200-day SMA: | 22.8 | Buy |
| 8-day EMA: | 38.55 | Buy |
| 20-day EMA: | 34.96 | Buy |
| 50-day EMA: | 30.68 | Buy |
| 200-day EMA: | 24.47 | Buy |
PagSeguro Digital Ltd. Earnings Growth & PAGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.23 per share, and an increase next year of $0.19 per share.
Enliven Therapeutics, Inc. Earnings Growth & ELVN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.60 per share.
PagSeguro Digital Ltd. Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | Apr 6 | Apr 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Enliven Therapeutics, Inc. Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | Apr 6 | Apr 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||